Surge in Counterfeit Injectables Prompts Safety Warning from AAFPRS
The AAFPRS is warning patients about the health dangers of counterfeit neuromodulators following FDA actions against companies selling unauthorized botulinum toxin products.
The AAFPRS is warning patients about the health dangers of counterfeit neuromodulators following FDA actions against companies selling unauthorized botulinum toxin products.
The new program is intended to offer practice partners incentives tied to purchases across its bio serums portfolio.